PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17363535-8	2007	RESULTS: Bexarotene-induced dosage-dependent repression of growth, cyclin D1, cyclin D3, total epidermal growth factor receptor (EGFR), and phospho-EGFR expression in BEAS-2B, BEAS-2B-R1, A427, and H358, but not H226 cells.	Bexarotene	9-19	epidermal growth factor receptor	Homo sapiens	95-127	
17363535-8	2007	RESULTS: Bexarotene-induced dosage-dependent repression of growth, cyclin D1, cyclin D3, total epidermal growth factor receptor (EGFR), and phospho-EGFR expression in BEAS-2B, BEAS-2B-R1, A427, and H358, but not H226 cells.	Bexarotene	9-19	epidermal growth factor receptor	Homo sapiens	129-133	
17363535-8	2007	RESULTS: Bexarotene-induced dosage-dependent repression of growth, cyclin D1, cyclin D3, total epidermal growth factor receptor (EGFR), and phospho-EGFR expression in BEAS-2B, BEAS-2B-R1, A427, and H358, but not H226 cells.	Bexarotene	9-19	epidermal growth factor receptor	Homo sapiens	148-152	
16314636-2	2005	The rexinoid, bexarotene, represses cyclin D1 and EGFR expression in vitro.	Bexarotene	14-24	epidermal growth factor receptor	Homo sapiens	50-54	
11479234-0	2001	Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.	Bexarotene	139-148	epidermal growth factor receptor	Homo sapiens	47-79